# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-036341
Filing Date
2025-03-10
Accepted
2025-03-10 16:25:20
Documents
9

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | 424b3_okur_10-k_2024_202.htm | 424B3 | 3906677
2 | GRAPHIC | img206454441_0.jpg | GRAPHIC | 8875
3 | GRAPHIC | img206454441_1.jpg | GRAPHIC | 458499
4 | GRAPHIC | img206454441_2.jpg | GRAPHIC | 611593
5 | GRAPHIC | img206454441_3.jpg | GRAPHIC | 118029
6 | GRAPHIC | img206454441_4.jpg | GRAPHIC | 107874
7 | GRAPHIC | img206454441_5.jpg | GRAPHIC | 75231
8 | GRAPHIC | img206454441_6.jpg | GRAPHIC | 649137
9 | GRAPHIC | img206454441_7.jpg | GRAPHIC | 1035305
| Complete submission text file | 0000950170-25-036341.txt |  | 8128236

Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-282792 | Film No.: 25724071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)